Replies to post #40160 on Vivos Inc (RDGL)

[druidfish]

One other point, the time to which you refer, between the 510k denial and de novo submission, was the period when ADMD diluted the stock by 1400%. From 130 mill to 2 billion shares. Interesting.

[bgrass1]

Are you saying a denovo application was never submitted on December 23rd 2014 by ADMD to the FDA?!!!

Is there no reference to the submission in subsequent SEC filings?

This is beyond stunning!!!

I was alarmed to hear that the CEO was unwilling to provide the application number!!